ESR1 and breast cancer: To be noted, the Y537 and D538 ER BC mutants are constitutively phosphorylated on S118 in an estrogen-independent manner [32,33], highlighting the importance of this phosphorylation event for ER activity and suggesting the S118 as a fundamental regulatory site in the drug-resistant metastatic disease.